22-04-2026 21:55 via wallstreet-online.de

Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto

Today, preliminary one-year follow-up data from the US PRESERVE trial of XVIVO's investigational heart technology, ‘PRESERVE: A Prospective, Multi-center, Single-arm, Open-label Study,' were presented by the trial's principal investigator, Dr. …
Weiterlesen »